Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer and other serious diseases. Its corporate objective is to become a fully-integrated biopharmaceutical company. The company was founded in 1982 and headquartered in Morris Plains, New Jersey.

UBI is a privately held multinational biopharmaceutical company dedicated to the discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. their product pipeline is filled with their new line of synthetic peptide-based biologicals for the treatment and prevention of Alzheimer’s Disease, AIDS, Autoimmune diseases, and Allergy, along with a portfolio of Animal health diseases. These products are based on their proprietary designer peptides, vaccine formulation systems, and methods to manufacture therapeutic monoclonal antibodies.

IDEC Pharmaceuticals develop therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases. Idec Pharmaceuticals was founded in 1986 by UC-San Diego physician and immunologist Ivor Royston, San Diego bioentrepreneur Howard Birndorf, and Stanford University cancer researchers Ron Levy and Richard Miller. In 2003, Idec Pharmaceuticals was merged with Biogen.

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Chiome Bioscience was established in 2005 to commercialize the innovative ADLib® antibody generation technology invented at RIKEN. Since that time the Company has worked on research and development for this system, as well as initiatives for technology licensing. It focused mainly on joint research and contract research with the research arms of pharmaceutical companies and academia. Meanwhile, in 2011 the Company was listed on the Mothers market of the Tokyo Stock Exchange, and in 2015 it merged with LivTech which focused on drug discovery and development of therapeutic antibody for oncology, thus adding drug discovery function. In 2017 the Company went through reorganization of the management team, switching its strategy from platform development to drug discovery and development. At the same time it started setting up the clinical function which enables us to run a clinical study aiming of significant increase in corporate value.

MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.

Zhu Hai Tai Nuo Mai Bo Zhi Yao Gu Fen You Xian Gong Si, established on 2015-12-17, Business scope includes general items:Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Natural science research and experimental development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;Import and export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:pharmaceutical production;Drug Wholesale;Drug retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Cellular Technology Ltd. (doing business as ImmunoSpot) is an American private company located in Cleveland, OH, that develops, manufactures and distributes standardized tools for specializing in cellular immune assays.

Hangzhou Heavy Chain Technology Co., Ltd., established on 2019-10-12, Business scope includes services:New Materials,Biotechnology,medical technology,Detection Technology,Technology development related to production and operation,technical consulting,technology transfer,Technology Promotion,Non-Certificate Occupational Labor for Adults,Instrumentation,Biological product,Gene,Testing of other specimens;Sales:Test Consumables,experimental reagent,laboratory apparatus.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Xiamen Kangji Biotechnology Co., Ltd., established on 2020-03-06, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technical extension services;Natural science research and experimental development;Medical Research and Experimental Development;Technology intermediary service;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of bio-based materials;Manufacturing of bio-based materials;Research and development of bio-based material polymerization technology.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:pharmaceutical production;Import and export;Technology Import and Export;Import and export agency.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration

Zhoushan Tongsheng Biotechnology Co., Ltd., established on 2009-08-25, Business scope includes bioengineering and biotechnology development.(Any certificate operation involving qualification or administrative license)

Shandong Minkang Biotechnology Co., Ltd., established on 2019-11-11, Business scope includes new materials,Technology research and development of biomedicine,Technology Promotion,Technical consulting services and transfer of technological achievements;biological reagent,Test Consumables,chemical reagent(Excluding hazardous chemicals),Sales of experimental equipment;Genetic Testing Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hunan Baikang Biotechnology Co., Ltd., established on 2021-07-15, Business scope includes biological products,Class I medical device,Class II medical device,Class III Medical Devices,cosmetic,Class II:6840Development of in vitro diagnostic reagents;Biotechnology Extension Services;biological reagent,Class I medical device,Class II medical device,Medical Laboratory Equipment and Appliance Sales;Medical device technology promotion service;Biological resources,Stem cell and immune cell storage and biotransformation medical technology services;Development of medical testing technology;Medical laboratory technical service;Science and Technology Information Consulting Services;medical information,Technical Advisory Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Do not engage in unauthorizedP2Ponline loan,Equity crowdfunding,internet insurance,Asset management and cross-border finance,Third party payment,virtual currency transaction,ICO,Internet financial services such as illegal foreign exchange)